AAIIT innovates the universal IgE allergy vaccine treatment to alleviate the severity of allergic syndromes and also seeks to alter the natural course of allergic asthma and rhinitis.
AAIIT licenses a portfolio of pipeline products and collaborates with the big Pharmas, and together we create a market niche generating revenues.
AAIIT serves our patients and clients in improving their quality of life (QoL).